bromerguride has been researched along with haloperidol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kehr, W; Sauer, G; Wachtel, H | 1 |
| Colpaert, FC; Pauwels, PJ; Tardif, S; Wurch, T | 1 |
2 other study(ies) available for bromerguride and haloperidol
| Article | Year |
|---|---|
Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Body Temperature; Brain; Catalepsy; Chemical Phenomena; Chemistry; Dopamine; Ergolines; Haloperidol; Humans; Lisuride; Male; Mice; Motor Activity; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior | 1983 |
Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alternative Splicing; Animals; Binding, Competitive; Butaclamol; Calcium; CHO Cells; Clozapine; Cricetinae; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Genotype; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Lisuride; Mutation; Plasmids; Receptors, Dopamine; Receptors, Dopamine D2; Recombinant Proteins; Sulfur Radioisotopes; Time Factors | 2001 |